Converting a tumor from checkpoint blockade-resistant to checkpoint blockade-sensitive: Immunotransplant for aggressive lymphoma.

被引：0
|
作者：
Marshall, Netonia
Hammerich, Linda
Upadhyay, Ranjan
Marron, Thomas Urban
Brody, Joshua
机构：
[1] Mt Sinai Hosp, Ichan Med Sch, New York, NY USA
[2] Icahn Sch Med Mt Sinai, New York, NY USA
[3] Mt Sinai Hosp, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e14538
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14538
引用
收藏
页数：2
相关论文
共 39 条
  • [21] Direct AKT activation in tumor-infiltrating lymphocytes markedly increases interferon-γ (IFN-γ) for the regression of tumors resistant to PD-1 checkpoint blockade
    François Santinon
    Bennani Fatima Ezzahra
    Meriem Bachais
    Alain Sarabia Pacis
    Christopher E. Rudd
    Scientific Reports, 12
  • [22] The oncolytic virus pelareorep primes the tumor microenvironment for checkpoint blockade therapy in early breast cancer patients: Results from AWARE-1 study
    Gavila Gregori, J.
    Loghmani, H.
    Manso Sanchez, L. M.
    Gonzalez, A.
    Pare Brunet, L.
    Salvador, F.
    Pascual, T.
    Gonzalez-Farre, B.
    Juan, M.
    Prat, A.
    Heineman, T. C.
    ANNALS OF ONCOLOGY, 2022, 33 : S126 - S126
  • [23] Discovery of WTX-330, a clinical stage conditionally activated IL-12 INDUKINE™ therapeutic with potent antitumor activity in murine syngeneic tumor models resistant to checkpoint blockade
    Nirschl, Christopher J.
    Brodkin, Heather R.
    Chopra, Sameer S.
    Dwyer, Connor J.
    Hicklin, Daniel J.
    Isaacs, Randi
    Ismail, Nesreen
    Seidel-Dugan, Cynthia
    Steuert, Zoe
    Sullivan, Jenna M.
    Winston, William M.
    Salmeron, Andres
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [24] Checkpoint blockade accelerates a novel switch from an NKT-driven TNFα response toward a T cell driven IFN-γ response within the tumor microenvironment
    Aoyama, Shota
    Nakagawa, Ryosuke
    Nemoto, Satoshi
    Perez-Villarroel, Patricio
    Mule, James J.
    Mailloux, Adam William
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (06)
  • [25] Bifunctional immunotherapeutic HCW9218 facilitates recruitment of immune cells from tumor draining lymph nodes to promote antitumor activity and enhance checkpoint blockade efficacy in solid tumors
    George, Varghese
    Chaturvedi, Pallavi
    Shrestha, Niraj
    Kanakraj, Leah
    Gilkes, Crystal
    Encalada, Nicole
    Wang, Meng
    Zhu, Xiaoyun
    Liu, Bai
    Rhode, Peter
    Wong, Hing C.
    CANCER RESEARCH, 2023, 83 (07)
  • [26] Beyond Immune Checkpoint Blockade: New Approaches to Targeting Host-Tumor Interactions in Prostate Cancer: Report From the 2014 Coffey-Holden Prostate Cancer Academy Meeting
    Miyahira, Andrea K.
    Kissick, Haydn T.
    Bishop, Jennifer L.
    Takeda, David Y.
    Barbieri, Christopher E.
    Simons, Jonathan W.
    Pienta, Kenneth J.
    Soule, Howard R.
    PROSTATE, 2015, 75 (04): : 337 - 347
  • [27] Two-Stage SN38 Release from a Core-Shell Nanoparticle Enhances Tumor Deposition and Antitumor Efficacy for Synergistic Combination with Immune Checkpoint Blockade ARTICLE
    Jiang, Xiaomin
    Lee, Morten
    Xia, Junjie
    Luo, Taokun
    Liu, Jianqiao
    Rodriguez, Megan
    Lin, Wenbin
    ACS NANO, 2022, 16 (12) : 21417 - 21430
  • [28] Enrichment of melanoma-associated T cells in 6-thioguanine-resistant T cells from the peripheral blood of a melanoma patient following successful treatment with immune checkpoint blockade.
    Albertini, Mark R.
    Zuleger, Cindy L.
    Newton, Michael A.
    Ma, Xiuyu
    Ong, Irene M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [29] BCL-2 inhibitor APG-2575 promotes anti-tumor efficacy of immune checkpoint blockade through converting tumor-associated macrophages into M1 phenotype in non-small cell lung cancer.
    Luo, Fan
    Lu, Fei Teng
    Qiu, Miao Zhen
    Pan, Wen Tao
    Zhang, Lin
    Zhao, Hong Yun
    Zhang, Li
    Yang, Da Jun
    CANCER RESEARCH, 2021, 81 (13)
  • [30] Impact of immune checkpoint protein expression in tumor cells and tumor infiltrating CD8+ T cells on clinical benefit from PD-1 blockade in metastatic clear cell renal cell carcinoma (mccRCC).
    Pigeon, Jean-Christophe
    Jegede, Opeyemi
    Mahoney, Kathleen M.
    Moreira, Raphael Brandao
    Novak, Jesse
    Conen, Hilla
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
1234